Re: [NVIC] HHS Buys Anthrax Vaccine for Attack

[Guest guest]

Think of all the good those billions of dollars could do for betterment of a

whole generation of children damaged by iatrogenic autism; a very real problem

we can see and touch as opposed to anthrax exposure and H5N1. Are they to be

forgotten for the greater good...again or will this tragedy soon be recognised

for what it really is and given the care and attention it deserves? Anyone?

Anita

Sheri Nakken <snakken@...> wrote:

http://www.detnews.com/apps/pbcs.dll/article?AID=/20060507/LIFESTYLE03/60507

Detroit News

Sunday, May 07, 2006

Government expands anthrax vaccine contract with Michigan company

Ken / Associated Press

WASHINGTON -- BioPort Corp. will receive $120 million to produce 5 million

more doses of anthrax vaccine to bolster the government's stockpile of

antidotes against bioweapons, the Department of Health and Human Services

said Friday.

BioPort, of Lansing, Mich., completed its delivery of 5 million doses of

anthrax vaccine to the federal stockpile in February under a $122.7 million

contract announced in May 2005. HHS officials said it would modify the

existing contract to purchase the additional doses of Anthrax Vaccine

Adsorbed.

" We are committed to protecting the nation from the consequences of an

anthrax attack, " said Simonson, HHS's assistant secretary for public

health emergency preparedness.

BioPort, a subsidiary of Gaithersburg, Md.-based Emergent Biosolutions Inc.,

is the nation's only licensed manufacturer of the anthrax vaccine.

The funding was awarded under Project BioShield, which was signed into law

by President Bush in July 2004 with the promise of spending $5.6 billion to

develop remedies against possible bioweapons.

Fuad El-Hibri, Emergent Biosolutions' chairman and CEO, said the company was

" proud to play a vital role in the strategic defense of the United States

and the protection of its citizens in the event of another anthrax attack. "

The contract would run through September 2007 and delivery of the doses

would begin almost immediately, said BioPort spokeswoman Kim Brennen Root.

Brisbane, Calif.-based VaxGen Inc. received the first contract worth $877.5

million to develop the company's experimental anthrax vaccine, but delivery

has been delayed.

---------------------------------

Talk is cheap. Use Messenger to make PC-to-Phone calls. Great rates

starting at 1 & cent;/min.

[Guest guest]

At 07:20 2006-05-09 -0700, you Anita Durney <mydurney@...>

wrote:

>Think of all the good those billions of dollars could do for betterment of

>a whole generation of children damaged by iatrogenic autism; a very real

>problem we can see and touch as opposed to anthrax exposure and H5N1. Are

>they to be forgotten for the greater good...again or will this tragedy

>soon be recognised for what it really is and given the care and attention

>it deserves? Anyone?

>

> Anita

I suspect that this tragedy basically will go on as long as those

who rule the world today still rule the world. No doubt many ordinary

people in many countries are seeing what is going on and want to

do something about it. They for now probably can force the ruling

minority into making some concessions on this and other issues.

But for a basic change to take place, the vast majority of people

need to take over this planet. A rather big program. But the only

realistic one in the long run, in my opinion.

Rolf M.

>

> Sheri Nakken <snakken@...> wrote:

>

><http://www.detnews.com/apps/pbcs.dll/article?AID=/20060507/LIFESTYLE03/60507>h\

ttp://www.detnews.com/apps/pbcs.dll/article?AID=/20060507/LIFESTYLE03/60507

>Detroit News

>Sunday, May 07, 2006

>

>

>Government expands anthrax vaccine contract with Michigan company

>

>Ken / Associated Press

>

>WASHINGTON -- BioPort Corp. will receive $120 million to produce 5 million

>more doses of anthrax vaccine to bolster the government's stockpile of

>antidotes against bioweapons, the Department of Health and Human Services

>said Friday.

>

>BioPort, of Lansing, Mich., completed its delivery of 5 million doses of

>anthrax vaccine to the federal stockpile in February under a $122.7 million

>contract announced in May 2005. HHS officials said it would modify the

>existing contract to purchase the additional doses of Anthrax Vaccine

>Adsorbed.

>

> " We are committed to protecting the nation from the consequences of an

>anthrax attack, " said Simonson, HHS's assistant secretary for public

>health emergency preparedness.

>

>BioPort, a subsidiary of Gaithersburg, Md.-based Emergent Biosolutions Inc.,

>is the nation's only licensed manufacturer of the anthrax vaccine.

>

>The funding was awarded under Project BioShield, which was signed into law

>by President Bush in July 2004 with the promise of spending $5.6 billion to

>develop remedies against possible bioweapons.

>

>Fuad El-Hibri, Emergent Biosolutions' chairman and CEO, said the company was

> " proud to play a vital role in the strategic defense of the United States

>and the protection of its citizens in the event of another anthrax attack. "

>

>The contract would run through September 2007 and delivery of the doses

>would begin almost immediately, said BioPort spokeswoman Kim Brennen Root.

>

>Brisbane, Calif.-based VaxGen Inc. received the first contract worth $877.5

>million to develop the company's experimental anthrax vaccine, but delivery

>has been delayed.

>

>

>----------